CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma

Clinical trial NCT02742727 · UNKNOWN

Trial details

NCT number: NCT02742727
Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Precursor T-Cell Lymphoblastic Leukemia-Lymphoma T-cell Prolymphocytic Leukemia T-cell Large Granular Lymphocytic Leukemia Peripheral T-cell Lymphoma, NOS Angioimmunoblastic T-cell Lymphoma Extranodal NK/T-cell Lymphoma, Nasal Type Enteropathy-type Intestinal T-cell Lymphoma Hepatosplenic T-cell Lymphoma

Start date: 2016-03-01
Primary completion: 2017-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.